Spruce Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Spruce Biosciences

16/03/2023 20:11

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended in December.
The mean expectation of six analysts for the quarter was for a
loss of 53 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Spruce Biosciences Inc's reported EPS for the quarter was
a loss
of 47 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Spruce Biosciences Inc shares had risen by 105.9% this
quarter.
    * The company reported a quarterly loss of $11.12 million.
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 08:11 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.53          -0.47          Beat
 Sep. 30 2022      -0.53          -0.48          Beat
 Jun. 30 2022      -0.52          -0.51          Beat
 Mar. 31 2022      -0.46          -0.50          Missed